212 related articles for article (PubMed ID: 16024605)
1. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.
Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD
Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells.
Reimer J; Bien S; Sonnemann J; Beck JF; Wieland T; Kroemer HK; Ritter CA
Anticancer Drugs; 2007 Mar; 18(3):333-40. PubMed ID: 17264767
[TBL] [Abstract][Full Text] [Related]
4. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI.
Golovanov AP; Chuang TH; DerMardirossian C; Barsukov I; Hawkins D; Badii R; Bokoch GM; Lian LY; Roberts GC
J Mol Biol; 2001 Jan; 305(1):121-35. PubMed ID: 11114252
[TBL] [Abstract][Full Text] [Related]
6. A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.
Yamamoto M; Torigoe T; Kamiguchi K; Hirohashi Y; Nakanishi K; Nabeta C; Asanuma H; Tsuruma T; Sato T; Hata F; Ohmura T; Yamaguchi K; Kurotaki T; Hirata K; Sato N
Cancer Res; 2005 Oct; 65(19):8706-14. PubMed ID: 16204039
[TBL] [Abstract][Full Text] [Related]
7. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
Lima RT; Martins LM; Guimarães JE; Sambade C; Vasconcelos MH
Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723
[TBL] [Abstract][Full Text] [Related]
8. GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis.
Essmann F; Wieder T; Otto A; Müller EC; Dörken B; Daniel PT
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):777-83. PubMed ID: 10698706
[TBL] [Abstract][Full Text] [Related]
9. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells.
Fawcett H; Mader JS; Robichaud M; Giacomantonio C; Hoskin DW
Int J Oncol; 2005 Dec; 27(6):1717-26. PubMed ID: 16273228
[TBL] [Abstract][Full Text] [Related]
10. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
11. An activating mutant of Cdc42 that fails to interact with Rho GDP-dissociation inhibitor localizes to the plasma membrane and mediates actin reorganization.
Gibson RM; Gandhi PN; Tong X; Miyoshi J; Takai Y; Konieczkowski M; Sedor JR; Wilson-Delfosse AL
Exp Cell Res; 2004 Dec; 301(2):211-22. PubMed ID: 15530857
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y
Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
[TBL] [Abstract][Full Text] [Related]
13. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
Bai J; Cederbaum AI
J Pharmacol Exp Ther; 2006 Dec; 319(3):1435-43. PubMed ID: 16971506
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
15. Regulation of breast cancer response to chemotherapy by fibulin-1.
Pupa SM; Giuffré S; Castiglioni F; Bertola L; Cantú M; Bongarzone I; Baldassari P; Mortarini R; Argraves WS; Anichini A; Menard S; Tagliabue E
Cancer Res; 2007 May; 67(9):4271-7. PubMed ID: 17483339
[TBL] [Abstract][Full Text] [Related]
16. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
[TBL] [Abstract][Full Text] [Related]
17. The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line.
Park YJ; Ahn HJ; Chang HK; Kim JY; Huh KH; Kim MS; Kim YS
Cell Signal; 2009 Feb; 21(2):356-64. PubMed ID: 19041939
[TBL] [Abstract][Full Text] [Related]
18. [The role of Hsp70 chaperone in the reaction of human leukemic cells to anticancer drugs].
Komarova EIu; Margulis BA; Guzhova IV
Tsitologiia; 2004; 46(6):550-6. PubMed ID: 15341131
[TBL] [Abstract][Full Text] [Related]
19. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
